AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Immunome Inc. Director's Dealing 2020

Oct 2, 2020

32238_dirs_2020-10-01_9287866e-4978-4aac-96ed-44363c022b47.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2020-10-01

Reporting Person: WAGENHEIM PHILIP (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	827640	Indirect
Common Stock	166666	Indirect

Footnotes

F1: The shares are held by BCM Advisory Partners LLC (the "LLC"). The Reporting Person is a managing member of the LLC and has voting and
investment power with respect to shares held by the LLC.

F2: The warrant is held by Rapoport Family Trust (the "Trust"). The Reporting Person is the trustee of the Trust and has voting and investment power with respect to shares held by the Trust.